Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
James Μ. Binley(San Diego Biomedical Research Institute), John R. Mascola(National Institute of Allergy and Infectious Diseases), George M. Shaw(International AIDS Vaccine Initiative), Georgia D. Tomaras(National Institutes of Health), Diane Wycuff(National Institutes of Health), Lynn Morris(National Health Laboratory Service), Cory Nathe(Fred Hutch Cancer Center), Katie L. Davis(Los Alamos National Laboratory), Elin S. Gray(Edith Cowan University), Douglas D. Richman(University of San Diego), Elizabeth A. Lybarger(National Institute of Allergy and Infectious Diseases), Natalie Hawkins(Fred Hutch Cancer Center), Michael S. Seaman(Beth Israel Deaconess Medical Center), Blake Wood(Fred Hutch Cancer Center), Linda Harris(Fred Hutch Cancer Center), James E. Robinson(Tulane University), Emma T. Crooks(San Diego Biomedical Research Institute), David C. Montefiori(Duke University), Frédéric Bibollet‐Ruche(University of Pennsylvania), Julie M. Decker(University of Alabama at Birmingham)
Cited by 355
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
|New England Journal of Medicine|1987|3k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k